Polymer microsphere integrated preparation device and preparation method based on microfluidic technology
By designing an integrated polymer microsphere preparation device based on microfluidic control technology, the asymmetric layout and flow rate controller of three channels realize controllable separation of oil and water phase and efficient collection of microspheres, solving the reagent consumption in traditional technology The problems of large, complex process and low collection efficiency have improved the efficiency of microsphere preparation and product quality.
Patent Information
- Application Number
- CN202411292361.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-14
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-09-14
AI Technical Summary
Traditional polymer microsphere preparation technology has problems such as large reagent consumption, complex process flow, difficult to control spherical shape and uneven particle size distribution, which limits the improvement of production efficiency and product quality, and the design of a single preparation channel of the microfluidic control device leads to The separation of oil and water phase is complicated and the collection efficiency of microspheres is low.
Design a polymer microsphere integrated preparation device based on microfluidic control technology, including a microfluidic drive device, a phase separation device and a collection device, and realizes controllable separation of oil and water phase through asymmetric layout and flow rate controller of three channels. and efficient collection of microspheres ensures spherical and dimensional uniformity of microspheres.
It significantly improves the efficiency of microsphere preparation, achieves high controllability, large-scale and continuous production, simplifies the device structure, improves the flexibility and adaptability of the preparation process, and ensures the uniformity and stability of microsphere products.
Smart Images

Figure CN118988185A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of microsphere preparation, and in particular relates to an integrated preparation device and method for polymer microspheres based on microfluidic technology. Background Art
[0002] Microspheres are widely used in the biomedical field in drug delivery systems, diagnostic reagents, tissue engineering and gene therapy due to their tiny size and special properties. As the core component of drug carriers, they are precisely embedded or firmly adsorbed into a polymer matrix to construct a particle system, showing excellent application potential. In the field of dye adsorption, some new microsphere materials such as hydrophilic-hydrophobic heterogeneous microspheres have been developed and successfully applied to the treatment of dye wastewater. Integrating the preparation process and improving production efficiency can further enhance its influence in the field.
[0003] At present, there are a wide range of technical paths for preparing such high-performance polymer microspheres, covering diversified methods such as emulsion polymerization, dispersion polymerization, seed polymerization, suspension polymerization, microsuspension polymerization, spray drying, and template method. However, traditional preparation devices are often subject to problems such as large reagent consumption, complex and lengthy process flow, difficulty in perfectly controlling the sphericity of microspheres, and uneven particle size distribution. These challenges greatly limit the further improvement of production efficiency and product quality. In view of this, the development of an innovative integrated preparation device for polymer microspheres has become a key task that the industry needs to solve urgently. The device aims to significantly improve preparation efficiency through technological innovation, while drastically reducing reagent consumption and optimizing the entire preparation process to ensure that microsphere products meet higher quality standards and consistency requirements.
[0004] Microfluidic technology, with its unique advantages, has gradually become an important force in promoting the upgrading of polymer microsphere preparation technology. Its core advantage lies in the exquisite use of microchannel design, which achieves efficient and precise preparation of microspheres by precisely controlling the fluid behavior at the microscale. However, traditional microfluidic devices are often limited by the design of a single preparation channel, resulting in a cumbersome oil-water phase separation process and low microsphere collection efficiency, which restricts its potential in large-scale production and industrial applications. Therefore, it is very necessary to develop a new device for preparing microspheres to solve the existing problems of oil-water phase separation, integrated preparation and low production efficiency. Summary of the invention
[0005] The purpose of the present invention is to overcome the defects of the prior art and provide an integrated preparation device and preparation method for polymer microspheres based on microfluidic technology. The device has the advantages of integration and miniaturization. By designing three channels, the controllable separation of oil and water phases is achieved based on the density of the phases themselves. The efficiency of microsphere preparation is greatly improved while ensuring the sphericity and size uniformity of the microspheres, thereby achieving highly controllable large-scale and continuous production.
[0006] In order to achieve the above objectives, one of the technical solutions of the present invention is: a polymer microsphere integrated preparation device based on microfluidic technology, comprising a microfluidic driving device, a phase separation device and a collecting device, wherein the microfluidic driving device comprises a dispersed phase fluid propeller, a continuous phase fluid propeller and a collecting phase fluid propeller; the phase separation device integrates a phase change channel, a continuous phase channel, a collecting phase channel and a flow rate controller, and the continuous phase channel is connected to the flow rate controller; the collecting device comprises a continuous phase collector and a microsphere collecting device, and the microsphere collecting device comprises a microsphere collector, a phase filtration membrane and a collecting phase collector; the inlet end of the phase separation device is connected to the dispersed phase fluid propeller, the continuous phase fluid propeller and the collecting phase fluid propeller, the outlet of the continuous phase channel is connected to one end of the flow rate controller, the other end of the flow rate controller is connected to the continuous phase collector, and the outlet of the collecting phase channel is connected to the microsphere collector.
[0007] The channels of the collection phase and the continuous phase are determined based on the density of the phases themselves. The flow rate controller is adjusted to adapt to the liquid flow rate of the three-phase fluid propeller, so that the preparation process is controllable, thereby realizing the integrated preparation of microfluidic microspheres.
[0008] In a preferred embodiment of the present invention, the phase change channel, continuous phase channel and collecting phase channel in the phase separation device adopt an asymmetric layout, and the three channels are arranged in a single channel structure and are not in the same horizontal plane, wherein the phase change channel is not fixed, but its phase is determined based on the density of the phase itself, when the density of the continuous phase fluid is greater than that of the collecting phase fluid, the collecting phase channel is closed, and the phase change channel is the collecting phase channel; when the density of the collecting phase is greater than that of the continuous phase, the continuous phase channel is closed, and the phase change channel is the continuous phase channel; the flow rate controller is connected to the continuous phase channel, and has a multi-speed flow rate adjustment function, and can ensure that the phase separation process runs stably in a fully controllable automatic mode by finely adjusting the flow rate of the continuous phase fluid.
[0009] In a preferred embodiment of the present invention, the microsphere collection device further comprises a phase filtration membrane and a microsphere collector to achieve efficient and accurate collection and purification of target microspheres.
[0010] When the integrated microsphere preparation device is in use, the configured dispersed phase fluid and continuous phase fluid are respectively placed in the dispersed phase fluid propeller and the continuous phase fluid propeller, and the propeller is used to drive the liquid flow; by adjusting and proportioning the flow rate of the propeller, the dispersed phase fluid can be sheared by the continuous phase fluid at the outlet of the connecting channel to become monodisperse microspheres, and flow out from the outlet of the continuous phase channel to the phase separation device along with the continuous phase fluid, and its channel is determined according to the density of the phase itself, and the flow rate controller is adjusted to adapt to the flow rate of the three-phase fluid so that the microspheres flow into the microsphere collector, and finally qualified microspheres can be obtained by freeze drying.
[0011] In a preferred embodiment of the present invention, the microspheres are polymer porous microspheres with loading function, the target load is loaded in the pore structure of the polymer porous microspheres, the target load includes but is not limited to organic small molecules, inorganic nanoparticles, and the particle size of the microspheres is 300-500 μm.
[0012] Further preferably, the material of the polymer porous microspheres includes one or more of hyaluronic acid and its derivatives, chondroitin sulfate and its derivatives, alginate and its derivatives, chitosan and its derivatives, and polylactic acid and its derivatives.
[0013] More preferably, the material of the polymer porous microspheres includes one or more of hyaluronic acid, chondroitin sulfate, alginate, chitosan and polylactic acid.
[0014] Still more preferably, the material of the polymer porous microspheres is one or more of hyaluronic acid and chondroitin sulfate.
[0015] In order to achieve the above objectives, the second technical solution of the present invention is: a method for preparing polymer microspheres based on an integrated polymer microsphere preparation device, comprising the following steps:
[0016] S1: injecting a continuous phase fluid and a dispersed phase fluid into a microfluidic device respectively to mix, obtaining polymer microspheres under the surface tension and shearing action of the continuous phase fluid, and freeze-drying the polymer microspheres to obtain the polymer porous microspheres;
[0017] S2: The obtained microspheres, continuous phase fluid and collecting phase fluid are injected into the separation phase device for mixing, and the polymer microspheres are separated from the continuous phase fluid and enter the collecting phase fluid; when the density of the continuous phase fluid is greater than that of the collecting phase fluid, the collecting phase channel is closed, and the polymer microspheres enter the microsphere collector along with the collecting phase fluid from the phase change channel, i.e., the collecting phase channel, and the continuous phase fluid is discharged from the continuous phase channel; when the density of the collecting phase fluid is greater than that of the continuous phase fluid, the continuous phase channel is closed, and the polymer microspheres enter the microsphere collector along with the collecting phase fluid from the collecting phase channel, and the continuous phase fluid is discharged from the phase change channel, i.e., the continuous phase channel.
[0018] In a preferred embodiment of the present invention, the dispersed phase fluid includes a modified polymer, a water-soluble salt, a photocuring agent and an inorganic solvent, wherein the inorganic solvent includes but is not limited to water, phosphate buffered saline (PBS), etc.; the continuous phase fluid includes but is not limited to ethyl acetate, dichloromethane (DCM) and other organic solvents; the collecting phase fluid includes but is not limited to water, PBS and other inorganic solvents.
[0019] Further preferably, the photocuring agent is phenyl (2,4,6-trimethylbenzoyl) lithium phosphate, and the water-soluble salt preferably includes one of sodium selenite, sodium permanganate and potassium permanganate, more preferably sodium selenite and sodium permanganate; the modified polymer preferably includes one or more of hyaluronic acid and its derivatives, chondroitin sulfate and its derivatives, alginate and its derivatives, chitosan and its derivatives, and polylactic acid and its derivatives; more preferably includes one or more of hyaluronic acid, chondroitin sulfate, alginate, chitosan and polylactic acid; further preferably includes one or more of hyaluronic acid and chondroitin sulfate.
[0020] Further preferably, the mass ratio of the modified polymer, the water-soluble salt, the photocuring agent and the inorganic solvent is 0.8-1.8:0.15-0.3:0.4-0.6:160-200.
[0021] Further preferably, the method for preparing the dispersed phase comprises the following steps: dissolving the modified polymer and the water-soluble salt in water respectively and then mixing them, and then adding a photocuring agent to obtain a dispersed phase solution.
[0022] In a preferred embodiment of the present invention, the injection rate of the dispersed phase fluid is 0.02-0.05 mL / min; the injection rate of the continuous phase fluid is 1.50-2.50 mL / min; the injection rate of the collected phase fluid is 1.50-2.50 mL / min;
[0023] In a preferred embodiment of the present invention, the mixing temperature of the preparation steps S1 and S2 is 20-30°C.
[0024] Further preferably, the mixing temperature of the preparation steps S1 and S2 is 25-30°C.
[0025] In order to achieve the above objectives, the third technical solution of the present invention is: a method for preparing polymer microspheres to obtain polymer microspheres.
[0026] In order to achieve the above objectives, the fourth technical solution of the present invention is: application of the above polymer microspheres in biomedicine and dye adsorption.
[0027] Compared with the prior art, the present invention has the following beneficial effects:
[0028] The microfluidic-based integrated microsphere preparation device designed in the present invention can be used to prepare polymer porous microspheres with load functions. By adjusting the flow rate controller to adapt to the liquid flow rate of the three-phase fluid propeller, the preparation process is controllable, thereby realizing the integrated preparation of microfluidic microspheres. Compared with the traditional microfluidic microsphere preparation device, the device structure is simplified, the flexibility and adaptability of the preparation process are improved, the high efficiency and accuracy of the microsphere preparation are ensured, and the uniformity and stability of the microsphere products are ensured. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 Flow chart for the integrated preparation of polymer microspheres based on microfluidics;
[0030] Figure 2 is a schematic diagram of a phase separation device;
[0031] Figure 3 It is a cross-sectional schematic diagram of the flow rate controller;
[0032] Figure 4 Schematic diagram of the microsphere collection device;
[0033] Figure 5 Schematic diagram of a molded microfluidic chip that can be used;
[0034] Figure 6 The GLP-MnO prepared in Example 2 2 Optical and SEM images of @ChSMA microspheres;
[0035] Figure 7 Optical and SEM images of HAMA / CS-Se@PDA microspheres prepared in Example 3;
[0036] Figure 8 HAMA / PEP@MnO prepared in Example 4 2 Optical image of microspheres, HAMA / PEP@MnO 2 Microspheres and HAMA / PEP@MnO 2 SEM image of / BC composite film;
[0037] Fig. 9 The GLP-MnO prepared in Example 2 2 @ChSMA microspheres and chondrocytes co-culture results;
[0038] Fig.10 This is a graph showing the biocompatibility analysis of HAMA / ChS-Se@PDA microspheres prepared in Example 3;
[0039] Fig.11To analyze the adsorption principle and mechanism obtained by fitting the kinetic model curve and the isothermal model;
[0040] In the figure: microfluidic driving device 1, dispersed phase fluid propeller 1-1, continuous phase fluid propeller 1-2, collecting phase fluid propeller 1-3, phase separation device 2, phase change channel 2-1, continuous phase channel 2-2, collecting phase channel 2-3, flow rate controller 2-4, flow rate controller switch 2-4-1, fluid main channel 2-5, pressure balance port 2-6, collecting device 3, continuous phase collector 3-1, microsphere collecting device 3-2, microsphere collector 3-2-1, phase filtration membrane 3-2-2, collecting phase collector 3-2-3, fluid connecting pipe 4, microfluidic chip 5. DETAILED DESCRIPTION
[0041] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention is described in more detail below with reference to the accompanying drawings and specific embodiments, but the protection scope of the present invention is not limited to these embodiments.
[0042] Example 1
[0043] A microfluidics-based integrated preparation device for polymer microspheres, such as Figure 1 As shown, it includes a microfluidic driving device 1, a phase separation device 2, a collecting device 3 and a fluid connecting pipe 4, wherein the microfluidic driving device 1 includes a dispersed phase fluid propeller 1-1, a continuous phase fluid propeller 1-2, and a collecting phase fluid propeller 1-3; the collecting device 3 includes a continuous phase collector 3-1 and a microsphere collecting device 3-2.
[0044] like Figure 2 As shown, the phase separation device 2 integrates a phase change channel 2-1, a continuous phase channel 2-2, a collection phase channel 2-3 and a flow rate controller 2-4, wherein the continuous phase channel 2-2 is connected to the flow rate controller 2-4; and also includes a fluid main channel 2-5 and a pressure balance port 2-6. The phase change channel 2-1, the continuous phase channel 2-2 and the collection phase channel 2-3 are arranged in a single channel structure and are not in the same horizontal plane, wherein the phase change channel 2-1 is not fixed, but determines its phase based on the density of the phase itself. When the density of the continuous phase fluid is greater than that of the collection phase fluid, the collection phase channel 2-3 is closed, and the phase change channel 2-1 becomes the collection phase channel 2-3; when the collection phase density is greater than that of the continuous phase, the continuous phase channel 2-2 is closed, and the phase change channel 2-1 becomes the continuous phase channel 2-2.
[0045] Figure 3 It is a cross-sectional schematic diagram of the flow rate controller 2-4. The four flow rate controller switches 2-4-1 can cope with the differentiated requirements for the liquid flow rate in the propeller during different microsphere preparation processes, ensuring that the liquid flow rate in the three-phase fluid propeller can be accurately matched and meet the specific requirements of each microsphere preparation process.
[0046] Figure 4 It is a schematic diagram of a microsphere collecting device 3-2, and its specific structure includes a microsphere collector 3-2-1, a phase filter membrane 3-2-2, a collection phase collector 3-2-3, etc.
[0047] The inlet end of the phase separation device 2 is connected to the dispersed phase fluid propeller 1-1, the continuous phase fluid propeller 1-2 and the collecting phase fluid propeller 1-3, the outlet of the continuous phase channel 2-2 is connected to one end of the flow rate controller 2-4, the other end of the flow rate controller 2-4 is connected to the continuous phase collector 2-1, and the outlet of the collecting phase channel 2-3 is connected to the microsphere collector 3-2-1.
[0048] Figure 5 Schematic diagram of the molded microfluidic chips that can be used, including (a) glass chip with integrated microchannels, (b) membrane emulsification chip, (c) simple catheter chip and (d) cross-type preparation chip.
[0049] Example 2
[0050] A polymer microsphere prepared by a microfluidics-based integrated polymer microsphere preparation device comprises the following steps:
[0051] (1) Under room temperature, weigh a certain amount of broken Ganoderma lucidum spore powder, add ethanol at a ratio of 1:30 (g / mL), stir evenly for 30 minutes, let stand, filter, continue to add solvent at a ratio of 1:30 (g / mL), repeat 3-4 times, and then place in an oven to dry at 60°C for standby use. Weigh 10g of defatted Ganoderma lucidum spore powder, fully mix with distilled water at a ratio of 1:30 (g / mL), then use ultrasonic treatment for 30 minutes, keep constant temperature at 60°C in a water bath for 2 hours, and finally use a centrifuge (8000r / min, 15min) to collect the filtrate, and reduce the pressure to concentrate to one third of the original volume. Add 10 times the volume of anhydrous ethanol to the concentrated polysaccharide solution for alcohol precipitation, and finally use a G4 sand core funnel to obtain the precipitate, dialyze it for 1-2 days, and vacuum freeze-dry it for 48 hours to obtain Ganoderma lucidum polysaccharide (GLP) for standby use.
[0052] (2) Under room temperature, 2 g of chondroitin sulfate (ChS) was dissolved in 50 mL of phosphate buffered saline (PBS; pH = 7.4). Then, 16.9 mL of methacrylic anhydride (MA) was added to the above solution. The pH was adjusted to about 8.0 with 5 M NaOH solution. After the reaction, the solution was magnetically stirred at 4°C for 24 hours, and then the solution was precipitated with ethanol. The solution was centrifuged (10000 rpm, 10 min) to obtain a precipitate, which was washed with ultrapure water and centrifuged again. The obtained precipitate was dissolved in ultrapure water and dialyzed for three days, and finally freeze-dried to obtain methacrylylated chondroitin sulfate (ChSMA).
[0053] (3) At room temperature, prepare 0.01M NaMnO 4 ·H 2 O solution and 20 mg / mL GLP solution were mixed in a 1:1 ratio to prepare a 5 mL solution, and magnetic stirring was used to make the solution react evenly. The reaction was complete after 24 h to obtain GLP-MnO 2 , then add 60 mg ChSMA and 10 mg phenyl-2,4,6-trimethylbenzoyl phosphate lithium salt (LAP), stir evenly and keep away from light for later use.
[0054] (4) The mixed solution was used as the dispersed phase, sucked into a 5mL syringe, connected to a microfluidic syringe, and the flow rate was set to 0.02mL / min; the mixed oil of 85wt% oil and 15wt% Span 80 was used as the continuous phase, sucked into a 50mL syringe, connected to a microfluidic syringe, and the flow rate was set to 1.50mL / min; PBS was used as the collection phase, sucked into a 50mL syringe, connected to a microfluidic syringe, and the flow rate was set to 1.50mL / min. Open the microfluidic syringe and use the formed microfluidic chip ( Figure 5 (a)) Preparation, GLP-MnO after photocuring 2 @ChSMA microspheres. Since the density of the continuous phase mixed oil is less than that of the collected phase water, the continuous phase channel is closed in the phase separation device, and GLP-MnO 2 @ChSMA microspheres enter the microsphere collection device along the collection phase channel, and the continuous phase mixed oil is discharged from the phase change channel, i.e., the continuous phase channel, and enters the continuous phase collector. Subsequently, the microspheres are washed with isopropanol to remove the oil, and then rinsed with PBS five times to obtain the prepared microspheres.
[0055] The GLP-MnO prepared in this example 2 @ChSMA microspheres were subjected to optical and SEM characterization analysis. The results are as follows Figure 6 shown. Figure 6 (a) and (b) show that the microspheres appear as uniform spheres under light microscopy, with a size of about 150-200 μm; Figure 6 (b) and (c) show that the pores of the microspheres are similar in size and evenly distributed. By magnifying the structure inside the pores, it can be seen that the elliptical GLP-MnO 2 NPs are evenly distributed on the surface of microspheres.
[0056] Example 3
[0057] A polymer microsphere prepared by a microfluidics-based integrated polymer microsphere preparation device comprises the following steps:
[0058] (1) 100 mL of sodium selenite (Na 2 SeO3 , 10 mM) solution was uniformly mixed with 100 mL of ascorbic acid (VC, 20 mM) solution in an ice bath environment, stirred for reaction for 12 h in the dark, and then the solution was centrifuged (12000 rpm, 10 min) to concentrate, and finally freeze-dried to obtain the reaction product, selenium nanoparticles (Se NPs), which were stored in a drying oven.
[0059] (2) At room temperature, 250 mg of ChS was added to 100 mL of Na 2 SeO 3 (10mM) solution, after it is evenly dissolved, the solution is transferred to an ice bath environment, and then 100mL VC (20mM) solution is added. After stirring for 12h in the dark, the solution is centrifuged (12000rpm, 10min) to concentrate, and finally freeze-dried to obtain the reaction product chondroitin sulfate grafted selenium nanoparticles (ChS-Se NPs), which are stored in a drying oven.
[0060] (3) At room temperature, 80 mg of the ChS-Se NPs prepared by the above reaction was mixed evenly with 50 mL of Tris-HCL (20 mM, pH = 8.8) solution, and then 50 mL of dopamine hydrochloride solution (1.6 mg / mL) was added dropwise. After vigorous stirring for 12 h, the solution was concentrated by centrifugation (12000 rpm, 10 min), and finally freeze-dried to obtain the reaction product, polydopamine-coated chondroitin sulfate grafted selenium nanoparticles (ChS-Se@PDANPs), which were stored in a drying oven.
[0061] (4) Prepare 100 mL of ultrapure water and N,N-dimethylformamide in a ratio of 2:1, add hyaluronic acid (HA) to prepare a 1 wt% HA solution, and stir at 37°C until completely dissolved. Add 4 mL of MA to the HA solution, and prepare 3M NaOH to maintain the pH at 8-9, and stir continuously at 4°C for 24 hours to obtain methacryloyl hyaluronic acid (HAMA). After dialyzing with ultrapure water for three days, freeze-drying is performed to obtain HAMA, and the solution is sealed and dried for storage.
[0062] (5) 80 mg of ChS-Se@PDANPs was dissolved in 10 mL of deionized water, and then 125 mg of HAMA was added and stirred evenly. After HAMA was completely dissolved, 25 mg of LAP was added and stirred evenly at room temperature in the dark to obtain a microfluidic dispersed phase solution, which was aspirated into a 5 mL syringe and connected to the microfluidic syringe. The flow rate was set to 0.04 mL / min. 2 Cl 2 As the continuous phase, a 50 mL syringe was inhaled and connected to the microfluidic syringe, and the flow rate was set to 2.50 mL / min; 2O as the collection phase, inhale into a 50mL syringe, connect the microfluidic syringe, and set the flow rate to 2.50mL / min. Open the microfluidic syringe and use the formed microfluidic chip ( Figure 5 (b)) to obtain the photocured HAMA / ChS-Se@PDA microspheres. 2 Cl 2 Density greater than the collection phase H 2 O, so in the phase separation device, the collection phase channel is closed, and the HAMA / ChS-Se@PDA microspheres enter the microsphere collection device from the phase change channel, i.e., the collection phase channel, along with the collection phase, and the continuous phase CH 2 Cl 2 It is discharged from the continuous phase channel and enters the continuous phase collector.
[0063] The HAMA / ChS-Se@PDA microspheres prepared in this example were characterized by optical and SEM analysis. Figure 7 shown. Figure 7 (a) The microspheres appear as uniform spheres under a light microscope, with a size of about 300 μm; Figure 7 (b) It can be seen that the prepared HAMA / ChS-Se@PDA microspheres are approximately spherical, with many void structures on them, which serve as drug loading sites.
[0064] Example 4
[0065] A polymer microsphere prepared by a microfluidics-based integrated polymer microsphere preparation device comprises the following steps:
[0066] (1) HAMA was prepared by the same method as above, and sealed and dried for storage.
[0067] (2) Dissolve 24 mg of purified Enteromorpha polysaccharide (PEP) in 4.7 mL of ultrapure water, and add 300 μL of 0.1 M NaMnO 4 The solution was reacted completely to obtain PEP@MnO 2 Solution. Add 62.5 mg HAMA and 13 mg LAP to the solution, stir evenly and set aside.
[0068] (3) The mixed solution was used as the dispersed phase and sucked into a 5 mL syringe. The microfluidic syringe was connected and the flow rate was set to 0.05 mL / min. 2 Cl 2 As the continuous phase, a 50 mL syringe was inhaled and connected to the microfluidic syringe, and the flow rate was set to 2.00 mL / min; 2 O as the collection phase, aspirate into a 50mL syringe, connect the microfluidic syringe, and set the flow rate to 2.00mL / min. Turn on the microfluidic syringe and use a simple microfluidic chip ( Figure 5 (c) Preparation, photocured HAMA / PEP@MnO was obtained at the collection port 2 Microspheres. Since the continuous phase CH 2 Cl 2 The density is greater than that of the collected phase water, so in the phase separation device, the collected phase channel is closed, and HAMA / PEP@MnO 2 The microspheres enter the microsphere collection device along with the collection phase from the phase change channel, i.e., the collection phase channel. The continuous phase CH 2 Cl 2 It is discharged from the continuous phase channel and enters the continuous phase collector.
[0069] (4) The prepared HAMA / PEP@MnO 2 The microspheres and BC were mixed evenly in a ratio of 1:10, and the evenly mixed HAMA / PEP@MnO was obtained after filtration. 2 / BC membrane (PMM) to verify the prepared HAMA / PEP@MnO 2 Adsorption properties of microspheres.
[0070] The HAMA / PEP@MnO prepared in this example 2 The microspheres and PMM were characterized by optical and SEM analysis. Figure 8 shown. Figure 8 (a) The microspheres appear as uniform spheres under a light microscope, with a size of about 450 μm; Figure 8 (b) It can be seen that the prepared PEP@MnO 2 The microspheres are approximately spherical and have many void structures, which can increase the adsorption sites of methylene blue. Figure 8 (c) It can be found that the microspheres are embedded on the surface and inside of the PMM, and the microspheres are distributed in various parts of the membrane and dispersed evenly.
[0071] Example 5
[0072] GLP-MnO prepared in Example 2 2 @ChSMA microspheres in biomedical applications:
[0073] like Fig. 9 As shown in (a), the lyophilized GLP-MnO 2 After co-culture of ChSMA microspheres and cells, the cells grew evenly on the surface of the microspheres and showed a good survival rate. Fig. 9 As shown in (b), more cells grew on the freeze-dried microspheres, which may be related to the porous structure of the microspheres after freeze-drying, providing more locations for cell growth. At the same time, the recruited cells were reconstructed in three dimensions. The results showed that the cells were able to grow on the GLP-MnO 2@ChSMA microspheres were attached and spread on the cells, indicating that the microspheres can provide cells with a three-dimensional network structure similar to the cartilage ECM ( Fig. 9 (c)).
[0074] Application of HAMA / ChS-Se@PDA microspheres prepared in Example 3 in biomedicine:
[0075] The biocompatibility of HAMA / ChS-Se@PDA microspheres was tested by CCK8 method and cell live-death staining. Fig.10 As shown in the figure, after Calcein / PI staining, some dead cells were found in the component with the maximum concentration of ChS-Se@PDA of 20 μg / mL, while no obvious cell killing effect was shown in the experiments of the components with a concentration of 0-10 μg / mL. This indicates that HAMA / ChS-Se@PDA microspheres have no obvious cytotoxicity and have good biocompatibility.
[0076] HAMA / PEP@MnO prepared in Example 4 2 Application of microspheres in dye adsorption:
[0077] The pseudo-first-order and pseudo-second-order kinetic models were used to investigate the thermal conductivity of bacterial cellulose membrane (BCM) and HAMA / PEP@MnO 2 The adsorption process of PMM / BC membrane (PMM) in MB solution was fitted to explore the adsorption principle of MB dye on the two membranes.
[0078] ln(Q.-Qt)-lnQe-k(1)
[0079]
[0080] Where Q e (mg / g) and Q t (mg / g) represents the adsorption capacity at equilibrium and time t(h), respectively. 1 and k 2 represents the pseudo-first-order kinetic rate constant (h -1 ) and pseudo-second-order kinetic rate constant (g / (mg·h)).
[0081] The experimental data were fitted with pseudo-first-order and pseudo-second-order kinetic models to obtain Fig.11 (a), (b) and Table 1. It can be found that the correlation coefficient of pseudo-first-order kinetics is higher than that of pseudo-second-order kinetics for both BCM and PMM, indicating that the pseudo-first-order kinetic equation is closer to the experimental results and can better represent the adsorption process of BCM and PMM on MB.
[0082] from Fig.11As can be seen from (a), the slope of the BCM fitting curve is smaller than that of the PMM, indicating that the adsorption rate constant k of BCM is 1 It is smaller than PMM, indicating that the addition of microspheres improves the adsorption rate of the membrane.
[0083] In addition, the Langmuir and Freundlich adsorption isotherm models were used to study the thermodynamics of the membrane and explore its surface properties and adsorption mechanism.
[0084]
[0085]
[0086] Where Q e (mg / g) represents the amount of MB adsorbed by the sample at equilibrium. m (mg / g) indicates the maximum adsorption capacity of the sample. L and K F are the Langmuir and Freundlich adsorption constants, respectively. e (mg / L) represents the mass concentration of the equilibrium solution. n is the dimensionless exponent of the Freundlich equation.
[0087] By fitting the Langmuir and Freundlich isotherm models, we can obtain Fig.11 (c), (d) and Table 1. It can be found that the correlation coefficient of the Freundlich isotherm model is higher than that of the Langmuir isotherm model for both BCM and PMM, indicating that the Freundlich isotherm model is closer to the experimental results and can better represent the adsorption process of BCM and PMM on MB. K F and n are smaller than those of PMM, indicating that the adsorption performance of PMM is better than that of BCM, which can further prove that the addition of microspheres is beneficial to the adsorption of MB solution by the membrane.
[0088] Table 1 shows the parameter results related to the kinetic and isothermal adsorption modeling of the PMM prepared in Example 4. From the results in Table 1, it can be seen that:
[0089] Whether BCM or PMM, the correlation coefficient of pseudo-first-order kinetics is higher than that of pseudo-second-order kinetics, indicating that the pseudo-first-order kinetic equation is closer to the experimental results; the correlation coefficient of the Freundlich isotherm model is higher than that of the Langmuir isotherm model, indicating that the Freundlich isotherm model is closer to the experimental results. Both results prove that the addition of microspheres is beneficial to the adsorption of MB solution by the membrane.
[0090] Table 1 Parameter results related to kinetic and isothermal adsorption modeling of PMM prepared in Example 2
[0091]
[0092] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some or all of the technical features thereof may be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. An integrated preparation device for polymer microspheres based on microfluidic technology, comprising a microfluidic driving device, a phase separation device and a collecting device, wherein the microfluidic driving device comprises a dispersed phase fluid propeller, a continuous phase fluid propeller and a collected phase fluid propeller; the phase separation device integrates a phase change channel, a continuous phase channel, a collected phase channel and a flow rate controller, and the continuous phase channel is connected to the flow rate controller; the collecting device comprises a continuous phase collector and a microsphere collecting device, and the microsphere collecting device comprises a microsphere collector, a phase filtration membrane and a collected phase collector; the inlet end of the phase separation device is connected to the dispersed phase fluid propeller, the continuous phase fluid propeller and the collected phase fluid propeller, the outlet of the continuous phase channel is connected to one end of the flow rate controller, the other end of the flow rate controller is connected to the continuous phase collector, and the outlet of the collected phase channel is connected to the microsphere collector.
2. The integrated polymer microsphere preparation device according to claim 1, characterized in that: The microspheres are polymer porous microspheres with a loading function, the target load is loaded in the pore structure of the polymer porous microspheres, and the particle size of the microspheres is 300-500 μm.
3. The integrated polymer microsphere preparation device according to claim 1, characterized in that: The material of the polymer porous microspheres includes one or more of hyaluronic acid and its derivatives, chondroitin sulfate and its derivatives, alginate and its derivatives, chitosan and its derivatives, and polylactic acid and its derivatives.
4. The integrated polymer microsphere preparation device according to claim 1, characterized in that: The phase change channel, continuous phase channel and collection phase channel in the phase separation device adopt an asymmetric layout. The three channels are arranged in a single channel structure and are not in the same horizontal plane. The phase change channel is not fixed, but its phase is determined based on the density of the phase itself. When the density of the continuous phase fluid is greater than that of the collection phase fluid, the collection phase channel is closed and the phase change channel becomes the collection phase channel; when the density of the collection phase is greater than that of the continuous phase, the continuous phase channel is closed and the phase change channel becomes the continuous phase channel. The flow rate controller is connected to the continuous phase channel.
5. A method for preparing polymer microspheres based on the polymer microsphere integrated preparation device according to any one of claims 1 to 4, characterized in that: The following steps are involved: S1: injecting a continuous phase fluid and a dispersed phase fluid into a microfluidic device respectively to mix, obtaining polymer microspheres under the surface tension and shearing action of the continuous phase fluid, and freeze-drying the polymer microspheres to obtain the polymer porous microspheres; S2: injecting the obtained microspheres, continuous phase fluid and collection phase fluid into a phase separation device for mixing, and the polymer microspheres are separated from the continuous phase fluid and enter the collection phase fluid; When the density of the continuous phase fluid is greater than that of the collection phase fluid, the collection phase channel is closed, the polymer microspheres enter the microsphere collector along with the collection phase fluid from the phase change channel, i.e., the collection phase channel, and the continuous phase fluid is discharged from the continuous phase channel; When the density of the collection phase fluid is greater than that of the continuous phase fluid, the continuous phase channel is closed, the polymer microspheres enter the microsphere collector from the collection phase channel along with the collection phase fluid, and the continuous phase fluid is discharged from the phase change channel, i.e., the continuous phase channel.
6. The method for preparing polymer microspheres according to claim 5, characterized in that: The dispersed phase fluid includes a modified polymer, a water-soluble salt, a photocuring agent and an inorganic solvent in a mass ratio of 0.8-1.8:0.15-0.3:0.4-0.6:160-200, wherein the inorganic solvent includes water and phosphate buffered saline; the continuous phase fluid includes but is not limited to ethyl acetate and dichloromethane; the collection phase fluid includes but is not limited to water and PBS.
7. The method for preparing polymer microspheres according to claim 6, characterized in that: The photocuring agent is phenyl (2,4,6-trimethylbenzoyl) lithium phosphate, the water-soluble salt includes one of ammonium selenite, sodium permanganate and potassium permanganate, and the modified polymer preferably includes one or more of hyaluronic acid and its derivatives, chondroitin sulfate and its derivatives, alginate and its derivatives, chitosan and its derivatives, and polylactic acid and its derivatives.
8. The method for preparing polymer microspheres according to claim 1, characterized in that: The injection rate of the dispersed phase fluid is 0.02-0.05 mL / min; the injection rate of the continuous phase fluid is 1.50-2.50 mL / min; and the injection rate of the collected phase fluid is 1.50-2.50 mL / min.
9. A polymer microsphere obtained by the method for preparing polymer microspheres according to any one of claims 5 to 8.
10. Use of the polymer microspheres as claimed in claim 9 in biomedicine and dye adsorption.
Citation Information
Patent Citations
A microfluidic microsphere preparation device
CN102284262A
Multichannel integrated micro-fluidic chip and method for preparing monodisperse gel microspheres in high-throughput manner by using multichannel integrated micro-fluidic chip
CN112275336A
Micro-droplet generation device and method based on microtube
CN117504959A
A micro -fluidic device for preparing microgel
CN205549077U
Process for producing emulsion and microcapsules and apparatus therefor
WO2002068104A1
